UTI Statistics
Total Valuation
UTI has a market cap or net worth of $2.40 billion. The enterprise value is $2.55 billion.
| Market Cap | 2.40B |
| Enterprise Value | 2.55B |
Important Dates
The last earnings date was Wednesday, May 6, 2026, after market close.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
UTI has 55.06 million shares outstanding. The number of shares has increased by 0.44% in one year.
| Current Share Class | 55.06M |
| Shares Outstanding | 55.06M |
| Shares Change (YoY) | +0.44% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 2.57% |
| Owned by Institutions (%) | 102.45% |
| Float | 49.67M |
Valuation Ratios
The trailing PE ratio is 57.29 and the forward PE ratio is 52.68. UTI's PEG ratio is 3.51.
| PE Ratio | 57.29 |
| Forward PE | 52.68 |
| PS Ratio | 2.76 |
| Forward PS | 2.53 |
| PB Ratio | 7.06 |
| P/TBV Ratio | 8.27 |
| P/FCF Ratio | 1,276.76 |
| P/OCF Ratio | 29.18 |
| PEG Ratio | 3.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.37, with an EV/FCF ratio of 1,358.62.
| EV / Earnings | 59.81 |
| EV / Sales | 2.94 |
| EV / EBITDA | 28.37 |
| EV / EBIT | 46.24 |
| EV / FCF | 1,358.62 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.93.
| Current Ratio | 1.17 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.93 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | 168.29 |
| Interest Coverage | 12.94 |
Financial Efficiency
Return on equity (ROE) is 13.47% and return on invested capital (ROIC) is 8.72%.
| Return on Equity (ROE) | 13.47% |
| Return on Assets (ROA) | 4.39% |
| Return on Invested Capital (ROIC) | 8.72% |
| Return on Capital Employed (ROCE) | 8.57% |
| Weighted Average Cost of Capital (WACC) | 9.94% |
| Revenue Per Employee | $211,948 |
| Profits Per Employee | $10,410 |
| Employee Count | 4,100 |
| Asset Turnover | 1.11 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, UTI has paid $13.83 million in taxes.
| Income Tax | 13.83M |
| Effective Tax Rate | 24.47% |
Stock Price Statistics
The stock price has increased by +22.29% in the last 52 weeks. The beta is 1.25, so UTI's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +22.29% |
| 50-Day Moving Average | 37.80 |
| 200-Day Moving Average | 31.48 |
| Relative Strength Index (RSI) | 61.88 |
| Average Volume (20 Days) | 1,552,753 |
Short Selling Information
The latest short interest is 3.29 million, so 5.98% of the outstanding shares have been sold short.
| Short Interest | 3.29M |
| Short Previous Month | 2.92M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 6.63% |
| Short Ratio (days to cover) | 5.02 |
Income Statement
In the last 12 months, UTI had revenue of $868.99 million and earned $42.68 million in profits. Earnings per share was $0.76.
| Revenue | 868.99M |
| Gross Profit | 482.53M |
| Operating Income | 55.21M |
| Pretax Income | 56.51M |
| Net Income | 42.68M |
| EBITDA | 89.98M |
| EBIT | 55.21M |
| Earnings Per Share (EPS) | $0.76 |
Balance Sheet
The company has $162.40 million in cash and $316.22 million in debt, with a net cash position of -$153.82 million or -$2.79 per share.
| Cash & Cash Equivalents | 162.40M |
| Total Debt | 316.22M |
| Net Cash | -153.82M |
| Net Cash Per Share | -$2.79 |
| Equity (Book Value) | 339.91M |
| Book Value Per Share | 6.17 |
| Working Capital | 35.85M |
Cash Flow
In the last 12 months, operating cash flow was $82.23 million and capital expenditures -$80.35 million, giving a free cash flow of $1.88 million.
| Operating Cash Flow | 82.23M |
| Capital Expenditures | -80.35M |
| Depreciation & Amortization | 34.77M |
| Net Borrowing | 36.22M |
| Free Cash Flow | 1.88M |
| FCF Per Share | $0.03 |
Margins
Gross margin is 55.53%, with operating and profit margins of 6.35% and 4.91%.
| Gross Margin | 55.53% |
| Operating Margin | 6.35% |
| Pretax Margin | 6.50% |
| Profit Margin | 4.91% |
| EBITDA Margin | 10.35% |
| EBIT Margin | 6.35% |
| FCF Margin | 0.22% |
Dividends & Yields
UTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.43% |
| Shareholder Yield | -0.43% |
| Earnings Yield | 1.78% |
| FCF Yield | 0.08% |
Analyst Forecast
The average price target for UTI is $42.50, which is -2.46% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | $42.50 |
| Price Target Difference | -2.46% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 9.07% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
UTI has an Altman Z-Score of 3.4 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.4 |
| Piotroski F-Score | 6 |